Radiation Device Allows for Targeted Breast Radiation to Control Cancer

 

July 12, 2010  |  

A new study of breast cancer patients at the Moores UCSD Cancer Center and the Arizona Oncology Services shows that after almost two years, the radiation given with the Strut-Adjusted Volume Implant (SAVI™) controls the rate of cancer and may reduce the complications seen with alternate types of brachytherapy. This study also demonstrates the accuracy and flexibility of the device to maximize the dose to the target tissue and minimize the exposure of healthy surrounding tissue and organs.

“This is the first paper that documents the patients’ status after almost two years,” said Catheryn Yashar, MD, associate professor of radiation oncology at the UC San Diego School of Medicine and chief of breast and gynecological radiation services at the Moores UCSD Cancer Center.   “After almost two years, the patients showed that the treatment was well-tolerated without experiencing significant side effects. To date, the control rate of cancer is also very promising.”

SAVI, which consists of comfortable, flexible catheters through which radiation is given, provides customized radiation therapy and minimizes exposure to healthy tissue after a woman who has undergone a lumpectomy to remove a cancerous tumor. Radiation specialists sometimes decide to give women internal radiation – a process called brachytherapy – with the goal of giving concentrated doses of radiation to areas of concern while avoiding healthy tissue.

These findings reported in the International Journal of Radiation Oncology, Biology and Physics showed the results of 102 patients treated at a median follow-up time of 21 months. The researchers found that the SAVI appears to safely allow an increase in eligibility for patients to receive Accelerated Partial Breast Irradiation (APBI) over balloon brachytherapy or three-dimensional conformal radiation.

“This treatment allows us to provide internal radiation to the area without damaging the healthy tissue around the site, and minimizes radiation to a duration of only five days,” explained Yashar.  “The traditional whole breast treatment usually takes approximately six weeks.”

Other authors of the clinical investigation include: Daniel Scanderbeg, Ph.D, Robert Kuske, MD, Anne Wallace, MD, Victor Zannis, MD, Sarah Blair, MD, Emily Grade, Virginia Swenson and Coral Quiet, MD.

The Moores UCSD Cancer Center is one of the nation’s 40 National Cancer Institute-designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer. For more information, visit http://cancer.ucsd.edu/    

# # #

Media Contact: Karen Shea, 619-543-6163, kshea@ucsd.edu




Media Contact

Share This Article


Related News

11/16/2017
That “to do” list of chores and errands could actually provide a variety of health benefits, according to researchers at the University of California San Diego School of Medicine. The study, published ...
11/15/2017
UC San Diego Health has expanded its treatment of rare brain tumors by launching a specialized program in the diagnosis and treatment of acoustic neuromas and complex skull base tumors. The new progra ...
11/14/2017
In an unprecedented move, UC San Diego Health and UCI Health have formed a strategic partnership to increase operational efficiencies and decrease patient care costs by sharing a single electronic med ...
11/14/2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, ...



Follow Us